Review article · 2023 · Open access
AI-powered therapeutic target discovery
Trends in Pharmacological Sciences, 44(9), 561–572 · Published 19 July 2023 · DOI 10.1016/j.tips.2023.06.010
In brief
“AI-powered therapeutic target discovery” is a 2023 review article by Frank W. Pun and 2 co-authors, published in Trends in Pharmacological Sciences. OpenAlex counts 412 citations as of 22 November 2026. It is open access under a CC BY-NC-ND licence: the full text is free to read at Trends in Pharmacological Sciences.
- Citations
- 412
- Most cited in
- 2025 (159)
- Field-weighted impact
- 6.09
- References
- 93
- Authors
- 3
Abstract
Disease modeling and target identification are the most crucial initial steps in drug discovery, and influence the probability of success at every step of drug development. Traditional target identification is a time-consuming process that takes years to decades and usually starts in an academic setting. Given its advantages of analyzing large datasets and intricate biological networks, artificial intelligence (AI) is playing a growing role in modern drug target identification. We review recent advances in target discovery, focusing on breakthroughs in AI-driven therapeutic target exploration. We also discuss the importance of striking a balance between novelty and confidence in target selection. An increasing number of AI-identified targets are being validated through experiments and several AI-derived drugs are entering clinical trials; we highlight current limitations and potential pathways for moving forward.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Pun, F. W., Ozerov, I. V., & Zhavoronkov, A. A. (2023). AI-powered therapeutic target discovery. Trends in Pharmacological Sciences, 44(9), 561–572. https://doi.org/10.1016/j.tips.2023.06.010
MLA 9
Pun, Frank W., et al. “AI-powered therapeutic target discovery.” Trends in Pharmacological Sciences, vol. 44, no. 9, 2023, pp. 561–572. https://doi.org/10.1016/j.tips.2023.06.010.
Chicago
Pun, Frank W., Ivan V. Ozerov, and Alex A. Zhavoronkov. 2023. “AI-powered therapeutic target discovery.” Trends in Pharmacological Sciences 44 (9): 561–572. https://doi.org/10.1016/j.tips.2023.06.010.
Harvard
Pun, F. W., Ozerov, I. V. and Zhavoronkov, A. A. (2023) ‘AI-powered therapeutic target discovery’, Trends in Pharmacological Sciences, 44(9), pp. 561–572. doi:10.1016/j.tips.2023.06.010.
IEEE
F. W. Pun, I. V. Ozerov, and A. A. Zhavoronkov, “AI-powered therapeutic target discovery,” Trends in Pharmacological Sciences, vol. 44, no. 9, pp. 561–572, 2023, doi: 10.1016/j.tips.2023.06.010.
BibTeX
@article{pun2023powered,
title = {{AI-powered therapeutic target discovery}},
author = {Pun, Frank W. and Ozerov, Ivan V. and Zhavoronkov, Alex A.},
journal = {Trends in Pharmacological Sciences},
year = {2023},
volume = {44},
number = {9},
pages = {561--572},
doi = {10.1016/j.tips.2023.06.010},
url = {https://doi.org/10.1016/j.tips.2023.06.010}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2017 | 1 | |
| 2023 | 15 | |
| 2024 | 111 | |
| 2025 | 159 | |
| 2026 | 126 |
Its field-weighted citation impact is 6.09: it has been cited 6.09 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- drug target identification
- artificial intelligence in drug discovery
- disease modeling
- drug target validation
- clinical trials
- drug development
- biological networks
Work with this paper
Most-cited papers in Pharmacology, Toxicology and Pharmaceutics
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingOleg Trott, Arthur J. Olson · Journal of Computational Chemistry · 2009 · 39,860 citations
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityGarrett M. Morris, Ruth Huey, William Lindstrom and 4 more · Journal of Computational Chemistry · 2009 · 26,508 citations
- Development and testing of a general amber force fieldJunmei Wang, Romain M. Wolf, James W. Caldwell and 2 more · Journal of Computational Chemistry · 2004 · 20,080 citations
- Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings 1PII of original article: S0169-409X(96)00423-1. The article was originally published in Advanced Drug Delivery Reviews 23 (1997) 3–25. 1Christopher A. Lipinski, Franco Lombardo, Beryl W. Dominy and 1 more · Advanced Drug Delivery Reviews · 2001 · 19,638 citations
- SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small moleculesAntoine Daina, Olivier Alain Michielin, Vincent Zoete · Scientific Reports · 2017 · 19,557 citations
All highly cited Pharmacology, Toxicology and Pharmaceutics papers
Questions about this paper
How do I cite this paper in APA style?
Pun, F. W., Ozerov, I. V., & Zhavoronkov, A. A. (2023). AI-powered therapeutic target discovery. Trends in Pharmacological Sciences, 44(9), 561–572. https://doi.org/10.1016/j.tips.2023.06.010
How many times has this paper been cited?
412 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Trends in Pharmacological Sciences: sign in and open the PDF from this page.
Who wrote this paper?
Frank W. Pun, Ivan V. Ozerov, Alex A. Zhavoronkov.
What is the DOI of this paper?
10.1016/j.tips.2023.06.010, permanently at https://doi.org/10.1016/j.tips.2023.06.010. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.